Companies / EPI

EPIMINDER LIMITED

ASX:EPIHealth Care Equipment & Services
216.7M shares on issueASX (delayed) · as of 28 July 2026$0.27price · delayed$65.0Mmarket cap · indicative
NR
Dilution gradeprovisional — limited history

Not rated — listed too recently to rate

Cash runway11.6 quarters of funding
Share-count growth (24m)0.0%
Raise cadence (24m)0 cash raises
Options & rights overhang0.0% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

EPIMINDER LIMITED listed in December 2025 and its disclosure history is short. There are no share-issuance (Appendix 2A) filings on record in the window, so no share-count series is available. The company did not raise capital in the 24-month window. At the March 2026 quarter EPIMINDER LIMITED reported A$75.2M in available cash, representing 11.6 quarters of cover. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
0.0%
Max option dilution
0.0%
ITM option dilution
0
Raises · last 12 months
11.6 qtrs
Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 216.7M per ASX (delayed) (28 July 2026).
215.8M216.7M217.5MDec 25Mar 26July 26

Cash runway

11.6 qtrs
More than four quarters of funding at the recent spend rate.
$75.2M available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 0 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

No issuance filings (Appendix 2A / 3G / 3H) on record.
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

No equity raises in the last 24 months.
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

No options or rights over unissued shares on record.

Director dealings

DateDirectorTypeSharesOptionsValueSource
2 June 2026Philip BinnsBuy11k——3Y notice
15 May 2026Jeffrey SellsBuy45k—$21k3Y notice
15 May 2026Robert KlupacsBuy10k—$5k3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

15 July 2026$PTrading Update
5 June 2026Change of Director's Interest Notice PB
31 May 2026$PDETECT Study reaches 25th enrolment as momentum builds
29 May 2026Change of Auditor
17 May 2026Change of Director's Interest Notice DO
17 May 2026Change of Director's Interest Notice PO
15 May 2026Change of Director's Interest Notice RK
15 May 2026Change of Director's Interest Notice JS
29 Apr 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
15 Apr 2026Change of Auditor
17 Mar 2026Change of Director's Interest Notice PB
3 Mar 2026Change of Director's Interest Notice RK
24 Feb 2026$P1H FY26 Results Presentation
24 Feb 2026$P1H FY26 Results Announcement
24 Feb 2026$P1HFY26 Appendix 4D and Financial Report
8 Feb 2026Notification of Results/Reporting Date
27 Jan 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
18 Jan 2026$PFirst Implant of Minder System in the US
16 Dec 2025$PFinalisation of historical R&D tax claims
15 Dec 2025Company Secretary Appointment/Resignation

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.